These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 11985330

  • 1. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z, Skuza G.
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [Abstract] [Full Text] [Related]

  • 2. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
    Rogóz Z, Dziedzicka-Wasylewska M.
    Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
    [Abstract] [Full Text] [Related]

  • 3. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J, Dziedzicka-Wasylewska M, Rogoz R, Rogóz Z.
    Eur J Pharmacol; 1998 Jun 12; 351(1):31-7. PubMed ID: 9698202
    [Abstract] [Full Text] [Related]

  • 4. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C, Biala G, Le Bihan C, Hamon M, Thiébot MH.
    Psychopharmacology (Berl); 2003 Feb 12; 166(1):19-32. PubMed ID: 12525958
    [Abstract] [Full Text] [Related]

  • 5. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J, Rogóz Z, Skuza G.
    J Neural Transm (Vienna); 1999 Feb 12; 106(11-12):1063-73. PubMed ID: 10651103
    [Abstract] [Full Text] [Related]

  • 6. Some behavioural effects of antidepressant drugs are time-dependent.
    Dziedzicka-Wasylewska M, Rogóz Z, Margas W, Dlaboga D, Góralska M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb 12; 25(2):373-93. PubMed ID: 11294483
    [Abstract] [Full Text] [Related]

  • 7. Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats.
    Rogóz Z, Dlaboga D, Dziedzicka-Wasylewska M.
    J Physiol Pharmacol; 2003 Jun 12; 54(2):257-70. PubMed ID: 12832726
    [Abstract] [Full Text] [Related]

  • 8. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I, Sághy K.
    Behav Pharmacol; 2004 Jul 12; 15(4):253-62. PubMed ID: 15252275
    [Abstract] [Full Text] [Related]

  • 9. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O.
    Behav Pharmacol; 2002 Dec 12; 13(8):633-8. PubMed ID: 12478213
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
    Barik S, de Beaurepaire R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 12; 29(5):718-26. PubMed ID: 15913875
    [Abstract] [Full Text] [Related]

  • 11. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists.
    Kolasiewicz W, Maj J.
    Pol J Pharmacol; 2001 Jun 12; 53(5):509-15. PubMed ID: 11990070
    [Abstract] [Full Text] [Related]

  • 12. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.
    Rogóz Z, Skuza G, Kłlodzińska A.
    Pol J Pharmacol; 2004 Jun 12; 56(5):519-26. PubMed ID: 15591639
    [Abstract] [Full Text] [Related]

  • 13. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement.
    Parsons LH, Caine SB, Sokoloff P, Schwartz JC, Koob GF, Weiss F.
    J Neurochem; 1996 Sep 12; 67(3):1078-89. PubMed ID: 8752115
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
    Mattingly BA, Caudill A, Abel M.
    Pharmacol Biochem Behav; 2001 Mar 12; 68(3):417-26. PubMed ID: 11325394
    [Abstract] [Full Text] [Related]

  • 15. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA, Himmler C, Bonta T, Rice LL.
    Psychopharmacology (Berl); 1998 Dec 12; 140(4):387-97. PubMed ID: 9888612
    [Abstract] [Full Text] [Related]

  • 16. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A.
    J Pharmacol Exp Ther; 1995 Dec 12; 275(3):1239-46. PubMed ID: 8531087
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ, Girardon S, Monneyron S, Dekeyne A.
    Neuropharmacology; 2000 Feb 14; 39(4):586-98. PubMed ID: 10728880
    [Abstract] [Full Text] [Related]

  • 18. Effect of repeated treatment with milnacipran on the central dopaminergic system.
    Rogóz Z, Margas W, Dlaboga D, Góralska M, Dziedzicka-Wasylewska M, Maj J.
    Pol J Pharmacol; 2000 Feb 14; 52(2):83-92. PubMed ID: 10949109
    [Abstract] [Full Text] [Related]

  • 19. The effect of repeated treatment with pramipexole on the central dopamine D3 system.
    Maj J, Rogói Z, Margas W, Kata M, Dziedzicka-Wasylewska M.
    J Neural Transm (Vienna); 2000 Feb 14; 107(12):1369-79. PubMed ID: 11458990
    [Abstract] [Full Text] [Related]

  • 20. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N, Kitamura M, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):235-41. PubMed ID: 8858293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.